Results 141 to 150 of about 165,956,709 (205)

Custom Triflange Acetabular and Femoral Components for Primary Hip Arthroplasty in a Patient With Severe Bone Defect: A Case Report. [PDF]

Cureus
Kumar D N, Bera AP, Basak M, Kang Y, Kim IB, Shon WY.   +5 more
europepmc   +1 more source

Subtrochanteric periprosthetic femoral fracture with a resurfacing metal-on-metal prosthesis in situ in an elderly patient: An increasing problem? - A case report and literature review. [PDF]

Trauma Case Rep
Plekkenpol LH, Olde Heuvel J, Homan AS, Brokelman RBG, Fransen BL.   +4 more
europepmc   +1 more source

'THA for DDH: replacement principles and techniques - femoral side'. [PDF]

EFORT Open Rev
Konstantinidis K, Grammatikopoulos D, Kenanidis E, Maslaris A, Dantas P, Tsiridis E.   +5 more
europepmc   +1 more source

Development of an automated landmarking tool for the femur in dual-energy X-ray absorptiometry scans using contour-based image analysis. [PDF]

JBMR Plus
Chu EM, Adachi JD, Quenneville CE.
europepmc   +1 more source

Factors influencing mechanical failure following intramedullary nailing of proximal femur fractures: a retrospective cohort study. [PDF]

Ulus Travma Acil Cerrahi Derg
Bavaneh MK, Güner B, Akayoglu YK, Koc E, Citgez AO, Cansi M.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

New England Journal of Medicine, 2010
A number of recent case reports and series have identified a subgroup of atypical fractures of the femoral shaft associated with bisphosphonate use. A population-based study did not support this association. Such a relationship has not been examined in randomized trials.We performed secondary analyses using the results of three large, randomized ...
Douglas Bauer, Dennis Black, Richard Eastell   +2 more
exaly   +3 more sources

Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study

Journal of Bone and Mineral Research, 2009
Udgivelsesdato: 2009-JunAlendronate (aln) is a potent bisphosphonate with a prolonged duration of action. Recent reports have found long-term aln use to be common in patients with subtrochanteric or proximal diaphyseal femur fracture, raising concerns ...
Richard Eastell, Bo Abrahamsen
exaly   +2 more sources

Subtrochanteric femur fractures

Orthopedic Clinics of North America, 2004
Subtrochanteric femur fractures have demanded special consideration in orthopaedic traumatology, given the high rate of complications associated with their management. The intense concentration of compression, tensile, and torsional stresses and decreased vascularity of the region has challenged orthopaedists with problems of malunion, delayed union ...
Asheesh, Bedi, T, Toan Le
openaire   +3 more sources

Subtrochanteric fractures of the femur

Injury, 1997
A consecutive series of 103 patients with a subtrochanteric fracture were prospectively studied. Ten patients were treated non-operatively, whilst the other 93 had operative treatment. The overall fixation failure rate was 12 per cent with a re-operation rate of 6 per cent by 1 year. There were six (8 per cent) failures of fixation for the 74 fractures
M J, Parker, B K, Dutta, C, Sivaji, G A, Pryor   +3 more
openaire   +2 more sources

Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort [PDF]

Journal of Bone and Mineral Research, 2011
Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid-induced osteoporosis. Case series suggest a potential link between prolonged use of bisphosphonates and low-energy fracture of subtrochanteric or diaphyseal femur as a ...
Levin, Raisa, Sebastian Schneeweiss, Daniel H Solomon, Kim, Seoyoung, Schneeweiss, Sebastian, Solomon, Daniel, Katz, Jeffrey, Seo Young Kim, Jeffrey N Katz, Raisa Levin   +9 more
exaly   +2 more sources